These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1955 related items for PubMed ID: 15897343

  • 1. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE.
    Circulation; 2005 May 24; 111(20):2605-10. PubMed ID: 15897343
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.
    Kidney Int; 2005 Nov 24; 68(5):2189-96. PubMed ID: 16221218
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.
    Am J Physiol Heart Circ Physiol; 2006 Nov 24; 291(5):H2166-72. PubMed ID: 16766648
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I, van Goor H, Turner AJ, Rushworth CA, Michaud AA, Corvol P, Navis G.
    Exp Physiol; 2008 May 24; 93(5):631-8. PubMed ID: 18192334
    [Abstract] [Full Text] [Related]

  • 5. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
    Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM.
    Hypertension; 1998 Feb 24; 31(2):699-705. PubMed ID: 9461243
    [Abstract] [Full Text] [Related]

  • 6. Converting enzyme determines plasma clearance of angiotensin-(1-7).
    Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM.
    Hypertension; 1998 Sep 24; 32(3):496-502. PubMed ID: 9740616
    [Abstract] [Full Text] [Related]

  • 7. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN, Yamada K, Diz DI, Ferrario CM, Chappell MC.
    J Cardiovasc Pharmacol; 2000 Jul 24; 36(1):109-17. PubMed ID: 10892668
    [Abstract] [Full Text] [Related]

  • 8. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K, Iyer SN, Chappell MC, Brosnihan KB, Fukuhara M, Ferrario CM.
    Regul Pept; 1999 Mar 17; 80(1-2):57-66. PubMed ID: 10235635
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures.
    Gowrisankar YV, Clark MA.
    J Neurochem; 2016 Jul 17; 138(1):74-85. PubMed ID: 27085714
    [Abstract] [Full Text] [Related]

  • 10. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW, Kwiecien S, Ptak-Belowska A, Pajdo R, Olszanecki R, Suski M, Madej J, Targosz A, Konturek SJ, Korbut R, Brzozowski T.
    J Physiol Pharmacol; 2016 Feb 17; 67(1):75-91. PubMed ID: 27010897
    [Abstract] [Full Text] [Related]

  • 11. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
    Gallagher PE, Chappell MC, Ferrario CM, Tallant EA.
    Am J Physiol Cell Physiol; 2006 Feb 17; 290(2):C420-6. PubMed ID: 16176966
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM.
    Hypertension; 2004 May 17; 43(5):970-6. PubMed ID: 15007027
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, Hyakkoku M, Taniguchi S, Shimamoto K.
    Hypertens Res; 2006 Nov 17; 29(11):865-74. PubMed ID: 17345786
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
    Iyer SN, Ferrario CM, Chappell MC.
    Hypertension; 1998 Jan 17; 31(1 Pt 2):356-61. PubMed ID: 9453328
    [Abstract] [Full Text] [Related]

  • 15. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
    Herath CB, Lubel JS, Jia Z, Velkoska E, Casley D, Brown L, Tikellis C, Burrell LM, Angus PW.
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul 17; 297(1):G98-G106. PubMed ID: 19389807
    [Abstract] [Full Text] [Related]

  • 16. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G, Amiri F, Garcia R.
    Regul Pept; 1997 Jan 29; 68(2):111-7. PubMed ID: 9110382
    [Abstract] [Full Text] [Related]

  • 17. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P, Lavandero S.
    Hypertension; 2006 Oct 29; 48(4):572-8. PubMed ID: 16908757
    [Abstract] [Full Text] [Related]

  • 18. Pouch tissue and angiotensin peptide generation.
    Katwa LC, Sun Y, Campbell SE, Tyagi SC, Dhalla AK, Kandala JC, Weber KT.
    J Mol Cell Cardiol; 1998 Jul 29; 30(7):1401-13. PubMed ID: 9710808
    [Abstract] [Full Text] [Related]

  • 19. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
    Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD.
    Am J Physiol Renal Physiol; 2010 Jun 29; 298(6):F1523-32. PubMed ID: 20357030
    [Abstract] [Full Text] [Related]

  • 20. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 98.